Latest filing published 12 Nov 2024 for OSE Immunotherapeutics, €300k. Read the official filing
Maryonne Hiance is a declared insider of OSE Immunotherapeutics (board member), with filings sourced from AMF. We count 3 filings; the first trade dates from 3 June 2024 and the latest from 8 November 2024.
On the market, this insider has only sold: 2 sales, €615k in total. The rest of the record consists of 1 option exercise.
On 12 November 2024 came the latest disclosure, an open-market sale for €300k in OSE Immunotherapeutics. Filings reach the AMF feed a median of 5 days after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from AMF. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations